Decreased antigen-specific T-cell proliferation by moDC among hepatitis B vaccine non-responders on haemodialysis

Clinical and Experimental Medicine

Volumn 7, Issue 2, 2007, Pages 65-71

  Verkade, M A ^a   Van Druningen, C J ^a   Op De Hoek, C T ^b   Weimar, W ^a   Betjes, M G H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SINT FRANCISCUS GASTHUIS   (Netherlands)

Author keywords

Antigen specific T cells; Dendritic cells; Haemodialysis; Hepatitis B; Non responders; Vaccination

Indexed keywords

CANDIDA ANTIGEN; CD4 ANTIGEN; HEAT SHOCK PROTEIN 65; TETANUS TOXOID;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; CELL FUNCTION; CELL MATURATION; CLINICAL ARTICLE; CLONING; COMPARATIVE STUDY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HEMODIALYSIS; HEPATITIS B; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; KIDNEY FAILURE; LYMPHOCYTE PROLIFERATION; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINATION;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; ANTIGENS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; FEMALE; HEAT-SHOCK PROTEINS; HEPATITIS B VACCINES; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MONOCYTES; RENAL DIALYSIS; T-LYMPHOCYTES;

CANDIDA; HEPATITIS B VIRUS;

EID: 34447128944     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-007-0127-x     Document Type: Article

References (26)

1. Litjens NH, van Druningen CJ, Betjes MG (2006) Progressive loss of renal function is associated with activation and depletion of naive T lymphocytes. Clin Immunol 118:83-91
2. Allon M, Depner TA, Radeva M et al (2003) Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol 14:1863-1870
3. Selroos O, Pasternack A, Virolainen M (1973) Skin test sensitivity and antigen-induced lymphocyte transformation in uraemia. Clin Exp Immunol 14:365-370
4. Maisonneuve P, Agodoa L, Gellert R et al (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354:93-99
5. Kruger S, Seyfarth M, Sack K et al (1999) Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination. Vaccine 17:1145-1150
6. Kreft B, Klouche M, Kreft R et al (1997) Low efficiency of active immunization against diphtheria in chronic hemodialysis patients. Kidney Int 52:212-216
7. Crosnier J, Jungers P, Courouce AM et al (1981) Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff. Lancet 1:455-459
8. DaRoza G, Loewen A, Djurdjev O et al (2003) Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis 42:1184-1192
9. Stevens CE, Alter HJ, Taylor PE et al (1984) Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med 311:496-501
10. de Graeff PA, Dankert J, de Zeeuw D et al (1985) Immune response to two different hepatitis B vaccines in haemodialysis patients: a 2-year follow-up. Nephron 40:155-160
11. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-252
12. Mellman I, Steinman RM (2001) Dendritic cells: specialized and regulated antigen processing machine. Cell 106:255-258
13. Grouard G, Durand I, Filgueira L et al (1996) Dendritic cells capable of stimulating T cells in germinal centres. Nature 384:364-367
14. Dubois B, Vanbervliet B, Fayette J et al (1997) Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J Exp Med 185:941-951
15. Fayette J, Durand I, Bridon JM et al (1998) Dendritic cells enhance the differentiation of naive B cells into plasma cells in vitro. Scand J Immunol 48:563-570
16. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109-1118
17. Verkade MA, van Druningen CJ, Vaessen LM et al (2007) Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease. Nephrol Dial Transplant 22:128-138
18. Van Schooten WC, Elferink DG, Van Embden J et al (1989) DR3-restricted T cells from different HLA-DR3-positive individuals recognize the same peptide (amino acids 2-12) of the mycobacterial 65-kDa heat-shock protein. Eur J Immunol 19:2075-2079
19. Anderson DC, van Schooten WC, Barry ME et al (1988) A mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide. Science 242:259-261
20. Sallusto F, Cella M, Danieli C et al (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182:389-400
21. Kitajima T, Caceres-Dittmar G, Tapia FJ et al (1996) T cellmediated terminal maturation of dendritic cells: loss of adhesive and phagocytotic capacities. J Immunol 175:2340-2347
22. Meuer SC, Hauer M, Kurz P et al (1987) Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest 80:743-749
23. Gibbons RA, Martinez OM, Garovoy MR (1990) Altered monocyte function in uremia. Clin Immunol Immunopathol 56:66-80
24. Verkade MA, Van De Wetering J, Klepper M et al (2004) Peripheral blood dendritic cells and GM-CSF as an adjuvantfor hepatitis B vaccination in hemodialysis patients. Kidney Int 66:614-621
25. Hesselink DA, Betjes MG, Verkade MA et al (2005) The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells. Nephrol Dial Transplant 20:1868-1873
26. Girndt M, Kaul H, Leitnaker CK et al (2001) Selective sequestration of cytokine-producing monocytes during hemodialysis treatment. Am J Kidney Dis 37:954-963